Related Experiment Videos
Combined valvular and coronary artery surgery
The Annals of Thoracic Surgery
|October 11, 1976
Summary
This study on combined valvular and coronary artery operations found a 16% operative mortality. Strategies to minimize myocardial ischemia during surgery were employed, with 8% late mortality observed.
Area of Science:
- Cardiovascular Surgery
- Cardiac Valve Disease
- Coronary Artery Disease
Background:
- Combined valvular and coronary artery operations address complex cardiac conditions.
- Patient demographics included a significant proportion with advanced New York Heart Association Functional Class IV and prior myocardial infarction.
- Coronary angiography revealed unexpected significant coronary artery disease in 14 patients.
Purpose of the Study:
- To evaluate the outcomes of combined valvular and coronary artery operations.
- To assess the safety and efficacy of a surgical strategy prioritizing coronary artery bypass grafting before valve replacement.
- To analyze operative and late mortality rates in patients undergoing this complex procedure.
Main Methods:
- A cohort of 45 patients underwent combined operations between 1971 and 1975.
- Procedures involved aortic, mitral, or tricuspid valve interventions alongside coronary artery bypass grafting.
- Grafts were performed before valve replacement, with continuous coronary perfusion to minimize ischemia.
Main Results:
- Aortic valve disease was the most common indication (30 patients), followed by mitral valve disease (13 patients).
- The average number of grafts per patient was 2.5.
- Operative mortality was 16%, with a late mortality of 8%. Two patients experienced perioperative myocardial infarction.
Conclusions:
- Combined valvular and coronary artery operations can be performed with acceptable mortality rates.
- The surgical technique of performing coronary artery bypass grafting before valve replacement, while maintaining perfusion, appears effective.
- Careful patient selection and surgical planning are crucial for managing patients with combined valve and coronary disease.